Reckitt Benckiser Group plc (RBGPF)

Consumer Defensive
Household & Personal Products
United Kingdom
Yahoo Finance  •  Trading View  •  Company site
Price
$75.55
▲ 0.00 (0.00%)
Market Cap
$51,380,629,504
Shares: 699,706,000
P/E
23.71
P/B: 5.05
ROE
21.29%
Current Ratio: 0.58
Fundamentals Score
62 (NEUTRAL)

Company Overview

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Headquarters: Turner House, Slough, SL1 3UH, United Kingdom  |  Employees: 37900  |  Website: reckitt.com
Key Contacts
IR / Phone: 44 17 5321 7800
Exchange: OQX
Industry: Household & Personal Products
Quick Financial Snapshot
Revenue$14,169,000,000
Net Income$1,426,000,000
Free Cash Flow$2,217,000,000
Book Value / Share$9.60

Balance Sheet & Liquidity

Total Liabilities$18,578,000,000
Total Equity$6,699,000,000
Debt / Equity1.29
Current Ratio0.58
Interest Coverage6.30
Working Capital$-3,345,000,000

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)23.71
Industry P/EN/A
Forward P/E17.65
P/B5.05
Price / Sales2.39
P / FCF15.25
EV / EBITDA14.14
Graham Number$20.95
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 60.66%
Operating Margin 17.11%
Net Margin 10.06%
ROIC 8.79%
Asset Turnover 0.56

Automated Fundamental Signals (Score: 62)

Passed
  • EPS shows upward trend
  • EPS CAGR 6.26%
  • ROIC 8.8%
  • Gross Margin 60.7%
  • P/FCF 15.25
  • Debt/Equity ratio
  • Operating Margin 17.1%
  • Positive Free Cash Flow
  • CapEx intensity
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
Failed
  • Price CAGR -2.18%
  • P/B Ratio 5.05
  • Current Ratio
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)

Price Chart (Candlestick)

Technical Analysis (Score: 75)

RSI (14)48.46
SMA 5075.42
SMA 20068.47
MACD0.11
Signal BULLISH
RSI 48.5, SMA trend bullish, momentum 24.9%.

Governance & Management

Governance scores: Audit: 7 | Board: 2 | Compensation: 3 | Shareholder Rights: 1
Executive Team
NameTitle
Mr. Kristoffer Loe Licht CEO & Executive Director (1976)
Ms. Shannon Sue Eisenhardt CFO & Executive Director (1974)
Mr. Nicholas James Ashworth C.F.A. Head of Investor Relations (—)
Ms. Catheryn O'Rourke Senior VP, General Counsel & Company Secretary (1973)
Ms. Sheila Redzepi Chief Communications & Corporate Affairs Officer (—)
Mr. Ranjay Radhakrishnan Chief Human Resources Officer (1971)
Mr. Jerome Lemaire President North America (1974)
Ms. Angela Naef Ph.D. Chief Research & Development Officer (1976)
Governance data last updated: 10/1/2025

Latest News

No news available for this company.

← Back